Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Dr. Reddy's Laboratories Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500124
ISIN Demat	INE089A01031
Book Value	332.64

NSE Code	DRREDDY
Dividend Yield %	0.69
Market Cap	971055.71

P/E	18.73
EPS	62.12
Face Value	1


	BSE		NSE

17-Apr-2025

Last Price	1163.70
Net Change	4.2
% Change	0.36%
Prev.Close	1159.50
Open	1150.00
High	1173.20
Low	1150.00
Volume	38382

Last Price	1163.60
Net Change	5.2
% Change	0.45%
Prev.Close	1158.40
Open	1150.10
High	1173.60
Low	1150.10
Volume	2788024

Value	44682932
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1173.20
52-Week High	1420.20
52-Week Low	1025.90

Value	3247579205.9
Best Buy	1163.60
Best Sell	0.00
Best Quantity	66
Sell Quantity	0
Today's Range	1173.60
52-Week High	1421.49
52-Week Low	1020.00

Open Price	1149.70
High Price	1171.30
Low Price	1147.80
Last Price	1162.70
Prev Close	1148.60
Change	14.10
% Change	1.23 %

Average Price	1162.57
Underlying Value	1163.60
Number of contracts traded	6349
Turnover in Rs. Lakhs	46132
Open Interest	14755630.00
Change in O I	-1378120.00
% Change in O I	-8.54 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	66
Price	1163.60

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	625
Price	1162.2

Quantity	625
Price	1162.9

Holding Details

Latest Corporate Events

Bonus

1 : 1

28-Aug-06

Book Closure

17-Jul-24

19-Jul-24

Dividend

800 %

17-Jul-24

Company News

16-04-2025

Dr. Reddy’s Laboratories ...

27-03-2025

Dr. Reddy’s arm inks comm...

24-03-2025

Dr. Reddy's arm sells mem...

20-03-2025

Dr Reddys Laboratories in...

12-03-2025

Dr Reddys Laboratories in...

27-02-2025

Dr. Reddy's raises after ...

25-02-2025

Dr. Reddy's gets EIR for ...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.